Max Gabriel Bronstein is named as a lobbyist on federal disclosure filings for 8 clients through Aviva Strategies (fka Mgb Consulting). The most recent filing naming them posted in October 2026. Issues reported include Health Issues and Medical/Disease Research/Clinical Labs.
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| ARPA-H GO | AVIVA STRATEGIES (FKA MGB CONSULTING) | Q3 2026 | Health Issues |
| ACT FOR ULTRA RARE | AVIVA STRATEGIES (FKA MGB CONSULTING) | Q3 2026 | Health Issues |
| ENDEAVOR BIOMEDICINES | AVIVA STRATEGIES (FKA MGB CONSULTING) | Q3 2026 | Science/Technology, Health Issues |
| ELEMENT BIOSCIENCES | AVIVA STRATEGIES (FKA MGB CONSULTING) | Q3 2026 | Science/Technology, Medical/Disease Research/Clinical Labs, Health Issues |
| ULTRAGENYX PHARMACEUTICAL | AVIVA STRATEGIES (FKA MGB CONSULTING) | Q1 2026 | Health Issues |
| HUNTINGTON'S DISEASE SOCIETY OF AMERICA | AVIVA STRATEGIES (FKA MGB CONSULTING) | Q4 2025 | Health Issues |
| BEAM THERAPEUTICS | AVIVA STRATEGIES (FKA MGB CONSULTING) | Q4 2025 | Health Issues |
| TAYSHA GENE THERAPIES | AVIVA STRATEGIES (FKA MGB CONSULTING) | Q4 2025 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 5 | 1 |
| 2025 | 4 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Max Gabriel Bronstein. See the Capitol Clarity rankings and method.